Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

S Rubinstein

Showing results (171-180 of 183) with videos related to

Pageof 19
Sort By:
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|March 21, 2012
Breast and ovarian cancer risk and risk reduction in Jewish BRCA1/2 mutation carriersBrian S Finkelman, Wendy S Rubinstein, Sue Friedman, et al.
Plos One|October 23, 2010
The rs10993994 risk allele for prostate cancer results in clinically relevant changes in microseminoprotein-beta expression in tissue and urineHayley C Whitaker, Zsofia Kote-Jarai, Helen Ross-Adams, et al.
JAMA|June 5, 2007
Founder and recurrent CDH1 mutations in families with hereditary diffuse gastric cancerPardeep Kaurah, Andrée MacMillan, Niki Boyd, et al.
Cell|March 25, 2017
Bedside Back to Bench: Building Bridges between Basic and Clinical Genomic ResearchTeri A Manolio, Douglas M Fowler, Lea M Starita, et al.
Cancer Research|July 30, 2011
Modification of BRCA1-Associated Breast and Ovarian Cancer Risk by BRCA1-Interacting GenesTimothy R Rebbeck, Nandita Mitra, Susan M Domchek, et al.
Plos Genetics|December 27, 2018
BRCA Challenge: BRCA Exchange as a global resource for variants in BRCA1 and BRCA2Melissa S Cline, Rachel G Liao, Michael T Parsons, et al.
Clinical Pharmacology and Therapeutics|October 20, 2015
Pharmacogenetic allele nomenclature: International workgroup recommendations for test result reportingL V Kalman, Jag Agúndez, M Lindqvist Appell, et al.
BJU International|September 16, 2010
Targeted prostate cancer screening in men with mutations in BRCA1 and BRCA2 detects aggressive prostate cancer: preliminary analysis of the results of the IMPACT studyAnita V Mitra, Elizabeth K Bancroft, Yolanda Barbachano, et al.
American Journal of Human Genetics|April 19, 2016
Point Mutations in Exon 1B of APC Reveal Gastric Adenocarcinoma and Proximal Polyposis of the Stomach as a Familial Adenomatous Polyposis VariantJun Li, Susan L Woods, Sue Healey, et al.
Human Genetics|May 21, 2011
Haplotype structure in Ashkenazi Jewish BRCA1 and BRCA2 mutation carriersKate M Im, Tomas Kirchhoff, Xianshu Wang, et al.
Pageof 19

Showing results (171-180 of 183) with videos related to

Sort By:
Pageof 19
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|March 21, 2012
Breast and ovarian cancer risk and risk reduction in Jewish BRCA1/2 mutation carriersBrian S Finkelman, Wendy S Rubinstein, Sue Friedman, et al.
Plos One|October 23, 2010
The rs10993994 risk allele for prostate cancer results in clinically relevant changes in microseminoprotein-beta expression in tissue and urineHayley C Whitaker, Zsofia Kote-Jarai, Helen Ross-Adams, et al.
JAMA|June 5, 2007
Founder and recurrent CDH1 mutations in families with hereditary diffuse gastric cancerPardeep Kaurah, Andrée MacMillan, Niki Boyd, et al.
Cell|March 25, 2017
Bedside Back to Bench: Building Bridges between Basic and Clinical Genomic ResearchTeri A Manolio, Douglas M Fowler, Lea M Starita, et al.
Cancer Research|July 30, 2011
Modification of BRCA1-Associated Breast and Ovarian Cancer Risk by BRCA1-Interacting GenesTimothy R Rebbeck, Nandita Mitra, Susan M Domchek, et al.
Plos Genetics|December 27, 2018
BRCA Challenge: BRCA Exchange as a global resource for variants in BRCA1 and BRCA2Melissa S Cline, Rachel G Liao, Michael T Parsons, et al.
Clinical Pharmacology and Therapeutics|October 20, 2015
Pharmacogenetic allele nomenclature: International workgroup recommendations for test result reportingL V Kalman, Jag Agúndez, M Lindqvist Appell, et al.
BJU International|September 16, 2010
Targeted prostate cancer screening in men with mutations in BRCA1 and BRCA2 detects aggressive prostate cancer: preliminary analysis of the results of the IMPACT studyAnita V Mitra, Elizabeth K Bancroft, Yolanda Barbachano, et al.
American Journal of Human Genetics|April 19, 2016
Point Mutations in Exon 1B of APC Reveal Gastric Adenocarcinoma and Proximal Polyposis of the Stomach as a Familial Adenomatous Polyposis VariantJun Li, Susan L Woods, Sue Healey, et al.
Human Genetics|May 21, 2011
Haplotype structure in Ashkenazi Jewish BRCA1 and BRCA2 mutation carriersKate M Im, Tomas Kirchhoff, Xianshu Wang, et al.
Pageof 19